Heinlein Plastik-Technik becomes a member of the ALPLA Group
The ALPLA Group is further expanding its pharma division ALPLApharma with its acquisition of Heinlein Plastik-Technik GmbH.
Pharmaceuticals, Biotechnology and Life Sciences
The ALPLA Group is further expanding its pharma division ALPLApharma with its acquisition of Heinlein Plastik-Technik GmbH.
At today’s Annual General Meeting (AGM) of Idorsia Ltd (SIX: IDIA) held in Basel, Switzerland, shareholders voted in favor of…
Clasado Biosciences has signed a new exclusive distribution agreement with Shanghai Prochin, a division of health ingredient specialist, Alliance Nutrition Group, which will see galactooligosaccharide ingredient Bimuno GOS made available to health and nutrition formulators in China, marking another exciting step in the commercial growth of Bimuno GOS.
Asgard Therapeutics, a privately held biotech company pioneering in vivo direct cell reprogramming for cancer immunotherapy, today announced it selected…
Banook Group, global provider of technology and services for clinical trial operators, today announces two strategic acquisitions that enhance its…
Benchling, the R&D Cloud powering the biotech industry, today announced that global pharmaceutical company Sanofi is using Benchling across more than 1,500…
NMD Pharma A/S, a clinical-stage biotech company dedicated to developing novel and improved treatments for patients living with neuromuscular diseases,…
CordenPharma and Certest are partnering up to add ionizable lipids to CordenPharma’s complex LNP formulation services
World Food Safety Day is jointly facilitated
by the Food and Agriculture Organization
of the United Nations (FAO) and the World
Health Organization (WHO), and aims to
draw attention and inspire action to help
prevent, detect and manage foodborne
risks, contributing to food security,
human health, economic prosperity,
agriculture, market access, tourism and
sustainable development.
Bristol Myers Squibb presented results from the Phase 3 CheckMate -9DW trial evaluating the dual immunotherapy combination of Opdivo® (nivolumab) plus Yervoy® (ipilimumab)…